Join the Chronic Obstructive Pulmonary Disease group to help and get support from people like you.
Chronic Obstructive Pulmonary Disease News (Page 4)
Related terms: Chronic Obstructive Pulmonary Disease, Acute, Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, COPD, Acute, COPD, Maintenance, Emphysema, Chronic Obstructive Pulmonary Disease, Maintenance, COPD
People With Chronic Liver Disease Face More Barriers to Health Care
THURSDAY, Aug. 29, 2024 – People with chronic liver disease (CLD) have a higher likelihood of barriers to health care, according to a study recently published in Gastro Hep Advances. Carrie R. Wong, ...
Americans Are Moving Away From Polluted Areas -- If They Can Afford To
MONDAY, Aug. 26, 2024 – Americans of means are fleeing heavily polluted places in the United States for cleaner locales, a new study has found. Pollution levels are a factor in families’ decision to ...
Improper Inhaler Use by People With COPD Is Common, Worsening Disease
FRIDAY, Aug. 23, 2024 – Millions of people rely on medicines delivered by an inhaler to help manage chronic obstructive pulmonary disorder (COPD). But a new European study finds many patients are...
Two-Thirds of COPD Hospitalized Patients Misuse Inhalers
FRIDAY, Aug. 23, 2024 – Among patients hospitalized with a diagnosis of chronic obstructive pulmonary disorder (COPD), two-thirds of inhalers assessed at admission are misused, according to a study...
Too Much Fun? Fireworks Displays Quickly Harm Air Quality
TUESDAY, Aug. 6, 2024 – Fireworks displays can cause worse air quality than wildfire smoke, a new study reveals. About 60,000 firework shells exploded over Manhattan’s East River as part of Macy’s Fo...
Filmmaker David Lynch Has Emphysema
TUESDAY, Aug. 6, 2024 – David Lynch, who transformed television and film with series such as "Twin Peaks" and movies like "Blue Velvet" and "Mulholland Drive," announced Monday that he is battling...
Wildfires Are Creating Hazardous Air Conditions in Western North America
FRIDAY, July 26, 2024 – Wildfires raging across the western parts of the United States and Canada are prompting air quality alerts and evacuation orders. Smoke and haze have filled the skies in...
Wildfires in Western U.S., Canada Create Hazardous Air Conditions
THURSDAY, July 25, 2024 – Wildfires raging in several states and Canada are triggering air quality alerts and evacuation orders across the western parts of the United States. Smoke and haze have...
FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)
LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayre...
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD
24 July 2020 – AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive p...
FDA Approves Duaklir Pressair (aclidinium bromide and formoterol fumarate) for Maintenance Treatment of Chronic Obstructive Pulmonary Disease
Oxford, UK – 1 April 2019: Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces the US Food and Dr...
FDA Approves ProAir Digihaler (albuterol sulfate) as the First and Only Digital Inhaler with Built-In Sensors
JERUSALEM--(BUSINESS WIRE)--Dec 21, 2018--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (a...
FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)
DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today...
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients with COPD
24 April 2018 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy...
FDA Medwatch Alert: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed
ISSUE: FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large...
Further information
Related drug support groups
prednisone, albuterol, Symbicort, Dupixent, Trelegy Ellipta, montelukast, dupilumab, Anoro Ellipta